References
- Adams, J. M., & Cory, S. (2007). The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene, 26(9), 1324–1337. https://doi.org/https://doi.org/10.1038/sj.onc.1210220
- Adekiya, T. A., Aruleba, R. T., Khanyile, S., Masamba, P., Oyinloye, B. E., & Kappo, A. P. (2017). Structural analysis and epitope prediction of MHC class-1-chain related protein-a for cancer vaccine development. Vaccines, 6(1), 1. https://doi.org/https://doi.org/10.3390/vaccines6010001
- Aruleba, R. T., Adekiya, T. A., Oyinloye, B. E., & Kappo, A. P. (2018). Structural studies of predicted ligand binding sites and molecular docking analysis of Slc2a4 as a therapeutic target for the treatment of cancer. International Journal of Molecular Sciences, 19(2), 386. https://doi.org/https://doi.org/10.3390/ijms19020386
- Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., Rollinger, J. M., Schuster, D., Breuss, J. M., Bochkov, V., Mihovilovic, M. D., Kopp, B., Bauer, R., Dirsch, V. M., & Stuppner, H. (2015). Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnology Advances, 33(8), 1582–1614. https://doi.org/https://doi.org/10.1016/j.biotechadv.2015.08.001
- Avraamides, C. J., Garmy-Susini, B., & Varner, J. A. (2008). Integrins in angiogenesis and lymphangiogenesis. Nature Reviews. Cancer, 8(8), 604–617. https://doi.org/https://doi.org/10.1038/nrc2353
- Brumby, A. M., & Helena, E. R. (2005). Using Drosophila melanogaster to map human cancer pathways. Nature Reviews. Cancer, 5(8), 626–639. https://doi.org/https://doi.org/10.1038/nrc1671
- Cicenas, J., & Valius, M. (2011). The CDK inhibitors in cancer research and therapy. Journal of Cancer Research and Clinical Oncology, 137(10), 1409–1418. https://doi.org/https://doi.org/10.1007/s00432-011-1039-4
- Dean, J. L., Thangavel, C., McClendon, A. K., Reed, C. A., & Knudsen, E. S. (2010). Therapeutic CDK4/6 inhibition in breast cancer: Key mechanisms of response and failure. Oncogene, 29(28), 4018–4032. https://doi.org/https://doi.org/10.1038/onc.2010.154
- DeSantis, C. E., Lin, C. C., Mariotto, A. B., Siegel, R. L., Stein, K. D., Kramer, J. L., Alteri, R., Robbins, A. S., & Jemal, A. (2014). Cancer treatment and survivorship statistics, 2014. CA: A Cancer Journal for Clinicians, 64(4), 252–271. https://doi.org/https://doi.org/10.3322/caac.21235
- Dixon, R. A., & Sumner, L. W. (2003). Legume natural products: Understanding and manipulating complex pathways for human and animal health. Plant Physiology, 131(3), 878–885. https://doi.org/https://doi.org/10.1104/pp.102.017319
- Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. The Journal of Chemical Physics, 103(19), 8577–8593. https://doi.org/https://doi.org/10.1063/1.470117
- Fadaka, A. O., Klein, A., & Pretorius, A. (2019). In silico identification of microRNAs as candidate colorectal cancer biomarkers. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 41(11), 31718480. https://doi.org/https://doi.org/10.1177/1010428319883721
- Fadaka, A. O., Pretorius, A., & Klein, A. (2019). MicroRNA assisted gene regulation in colorectal cancer. International Journal of Molecular Sciences, 20(19), 4899. https://doi.org/https://doi.org/10.3390/ijms20194899
- Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47(7), 1750–1759. https://doi.org/https://doi.org/10.1021/jm030644s
- Hoover, W. G. (1985). Canonical dynamics: Equilibrium phase-space distributions. Physical Review A, 31(3), 1695–1697. https://doi.org/https://doi.org/10.1103/PhysRevA.31.1695
- Huang, N., Kalyanaraman, C., Bernacki, K., & Jacobson, M. P. (2006). Molecular mechanics methods for predicting protein-ligand binding. Physical Chemistry Chemical Physics: Pccp, 8(44), 5166–5177. https://doi.org/https://doi.org/10.1039/b608269f
- Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., & Selkoe, D. J. (2011). Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proceedings of the National Academy of Sciences, 108(14), 5819–5824. https://doi.org/https://doi.org/10.1073/pnas.1017033108
- Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/https://doi.org/10.1063/1.445869
- Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44(D1), D1202–D13. https://doi.org/https://doi.org/10.1093/nar/gkv951
- Kitano, H. (2002). Systems biology: A brief overview. Science (New York, NY), 295(5560), 1662–1664. https://doi.org/https://doi.org/10.1126/science.1069492
- Laderian, B., & Fojo, T. (2017). CDK4/6 inhibition as a therapeutic strategy in breast cancer: Palbociclib, ribociclib, and abemaciclib. Seminars in Oncology, 44(6), 395–403. https://doi.org/https://doi.org/10.1053/j.seminoncol.2018.03.006
- Le Sage, C., & Agami, R. (2006). Immense promises for tiny molecules: Uncovering miRNA functions. Cell Cycle (Georgetown, TX), 5(13), 1415–1421. https://doi.org/https://doi.org/10.4161/cc.5.13.2890
- Ligprep, M., & Macromodel, G. (2011). QikProp: Schrodinger, LLC.
- Lin, F., Xie, B., Cai, F., & Wu, G. (2012). Protective effect of puerarin on β-amyloid-induced neurotoxicity in rat hippocampal neurons. Arzneimittel-Forschung, 62(4), 187–193. https://doi.org/https://doi.org/10.1055/s-0031-1299763
- Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44(1), 235–249. https://doi.org/https://doi.org/10.1016/S1056-8719(00)00107-6
- Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today. Technologies, 1(4), 337–341. https://doi.org/https://doi.org/10.1016/j.ddtec.2004.11.007
- Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1–3), 3–25. https://doi.org/https://doi.org/10.1016/S0169-409X(96)00423-1
- Lyne, P. D., Lamb, M. L., & Saeh, J. C. (2006). Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. Journal of Medicinal Chemistry, 49(16), 4805–4808. https://doi.org/https://doi.org/10.1021/jm060522a
- Ma, X., & Yu, H. (2006). Global burden of cancer. The Yale Journal of Biology and Medicine, 79(3–4), 85–94.
- Meng, X. Y., Zheng, Q. C., & Zhang, H. X. (2009). A comparative analysis of binding sites between mouse CYP2C38 and CYP2C39 based on homology modeling, molecular dynamics simulation and docking studies. Biochimica et Biophysica Acta, 1794(7), 1066–1072. https://doi.org/https://doi.org/10.1016/j.bbapap.2009.03.021
- Ojo, O. A., Afon, A. A., Ojo, A. B., Ajiboye, B. O., Okesola, M. A., Aruleba, R. T., Adekiya, T. A., & Oyinloye, B. E. (2019). Spondias mombim L. (Anacardiaceae): Chemical fingerprints, inhibitory activities, and molecular docking on key enzymes relevant to erectile dysfunction and Alzheimer’s diseases. Journal of Food Biochemistry, 43(3), e12772. https://doi.org/https://doi.org/10.1111/jfbc.12772
- Ojo, O. A., Ojo, A. B., Ajiboye, B. O., Olaiya, O., Okesola, M. A., Boligon, A. A., de Campos, M. M. A., Oyinloye, B. E., & Kappo, A. P. (2018). HPLC-DAD fingerprinting analysis, antioxidant activities of Tithonia diversifolia (Hemsl.) A. Gray leaves and its inhibition of key enzymes linked to Alzheimer's disease. Toxicology Reports, 5, 585–592. https://doi.org/https://doi.org/10.1016/j.toxrep.2018.05.003
- Ojo, O. A., Ojo, A. B., Ajiboye, B. O., Oyinloye, B. E., Akinyemi, A. J., Okesola, M. A., Boligon, A. A., & de Campos, M. M. A. (2018). Chromatographic fingerprint analysis, antioxidant properties, and inhibition of cholinergic enzymes (acetylcholinesterase and butyrylcholinesterase) of phenolic extracts from Irvingia gabonensis (Aubry-Lecomte ex O’Rorke) Baill bark. Journal of Basic and Clinical Physiology and Pharmacology, 29(2), 217–224. https://doi.org/https://doi.org/10.1515/jbcpp-2017-0063
- Oyinloye, B. E., Adekiya, T. A., Aruleba, T., Ojo, O. A., & Ajiboye, B. O. (2019). Structure-based docking studies of GLUT4 towards exploring selected phytochemicals from Solanum xanthocarpum as a therapeutic target for the treatment of cancer. Current Drug Discovery Technologies, 16(4), 406–416. https://doi.org/https://doi.org/10.2174/1570163815666180801152110
- Parvez, M. K. (2018). Natural or plant products for the treatment of neurological disorders: Current knowledge. Current Drug Metabolism, 19(5), 424–428. https://doi.org/https://doi.org/10.2174/1389200218666170710190249
- Pengyu, S., Ahmad, B., & Lijuan, Z. (2018). Natural β-elemene: Advances in targeting cancer through different molecular pathways. North American Academic Research, 1(4), 27.
- Prasad, S., Phromnoi, K., Yadav, V. R., Chaturvedi, M. M., & Aggarwal, B. B. (2010). Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Medica, 76(11), 1044–1063. https://doi.org/https://doi.org/10.1055/s-0030-1250111
- Rios, J. L., Francini, F., & Schinella, G. R. (2015). Natural products for the treatment of type 2 diabetes mellitus. Planta Medica, 81(12–13), 975–994. https://doi.org/https://doi.org/10.1055/s-0035-1546131
- Scheer, A., Fanelli, F., Costa, T., De Benedetti, P. G., & Cotecchia, S. (1996). Constitutively active mutants of the alpha 1B‐adrenergic receptor: Role of highly conserved polar amino acids in receptor activation. The EMBO Journal, 15(14), 3566–3578. https://doi.org/https://doi.org/10.1002/j.1460-2075.1996.tb00726.x
- Shulman, L. N., & Mok, T. S. K. (2016). Special issue on global cancer medicine. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 34(1), 1–2. https://doi.org/https://doi.org/10.1200/JCO.2015.64.6067
- Tammela, T., Zarkada, G., Wallgard, E., Murtomäki, A., Suchting, S., Wirzenius, M., Waltari, M., Hellström, M., Schomber, T., Peltonen, R., Freitas, C., Duarte, A., Isoniemi, H., Laakkonen, P., Christofori, G., Ylä-Herttuala, S., Shibuya, M., Pytowski, B., Eichmann, A., Betsholtz, C., & Alitalo, K. (2008). Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature, 454(7204), 656–660. https://doi.org/https://doi.org/10.1038/nature07083
- Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65(2), 87–108. https://doi.org/https://doi.org/10.3322/caac.21262
- Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/https://doi.org/10.1021/jm020017n
- Wei, S. Y., Chen, Y., & Xu, X. Y. (2014). Progress on the pharmacological research of puerarin: A review. Chinese Journal of Natural Medicines, 12(6), 407–414. https://doi.org/https://doi.org/10.1016/S1875-5364(14)60064-9
- Wootten, D., Reynolds, C. A., Smith, K. J., Mobarec, J. C., Furness, S. G. B., Miller, L. J., Christopoulos, A., & Sexton, P. M. (2016). Key interactions by conserved polar amino acids located at the transmembrane helical boundaries in Class B GPCRs modulate activation, effector specificity and biased signalling in the glucagon-like peptide-1 receptor. Biochemical Pharmacology, 118, 68–87. https://doi.org/https://doi.org/10.1016/j.bcp.2016.08.015
- Yang, C., Fan, X., & Fan, S. (2018). Effects and mechanism of puerarin on the human retinoblastoma cells. Journal of Cellular Biochemistry, 119(6), 4506–4513. https://doi.org/https://doi.org/10.1002/jcb.26565
- Yu, Z., & Li, W. (2006). Induction of apoptosis by puerarin in colon cancer HT-29 cells. Cancer Letters, 238(1), 53–60. https://doi.org/https://doi.org/10.1016/j.canlet.2005.06.022
- Yu, Z., Jacobson, M. P., & Friesner, R. A. (2006). What role do surfaces play in GB models? A new-generation of surface-generalized born model based on a novel Gaussian surface for biomolecules. Journal of Computational Chemistry, 27(1), 72–89. https://doi.org/https://doi.org/10.1002/jcc.20307
- Zhao, M., Du, Y. Q., Yuan, L., & Wang, N. N. (2010). Protective effect of puerarin on acute alcoholic liver injury. The American Journal of Chinese Medicine, 38(2), 241–249. https://doi.org/https://doi.org/10.1142/S0192415X10007816